FASN and hepatocellular carcinoma: Moreover, cell cycle analysis indicated a decrease in the S phase when HCC cells were subjected to C75 (25 μM) administration (Figure 3), si-FASN treatment, and, to a lesser extent, si-SKP2 treatment (Figure 4).